Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

Drug Risk Versus Benefit

Gretchen Henkel  |  April 1, 2009

Perceptions from the FDA, physicians, and patients

Filed under:Uncategorized Tagged with:BiologicsDisease-modifying antirheumatic drugs (DMARDs)FDASafety

Demonstrators Demand More Money for Arthritis Research—What Could Happen?

Leslie Crofford, MD  |  March 1, 2009

I recently came across a fictional publication called the Not Yet Gazette with a front-page story dated November 10, 2025, entitled, “Demonstrators demand more money for arthritis research.” The fictional report gave details of a crowd of 100,000, “many in wheelchairs,” confronting the health secretary of that time. The genesis of this fictional article was the observed trend towards the aging of the population and slow growth in research funding. The article stated that, “ ‘Fiscal constraints caused by slow economic growth and resistance to tax increases have greatly reduced allocations for medical research grants in recent years,’ [the health secretary] told the delegates. ‘Unfortunately, in our current political climate, funding for health research is limited,’ she said to reporters after the meeting. ‘We have to devote our limited resources to diseases that are more immediately life-threatening.’ ”

Filed under:From the CollegeResearch Rheum Tagged with:REF NewsResearch

Gout

Staff  |  March 1, 2009

Patient Fact Sheet

Filed under:ConditionsFrom the CollegeGout and Crystalline Arthritis Tagged with:GoutPatient Fact Sheet

Coding Corner Question

Staff  |  March 1, 2009

March’s Coding Challenge

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingOsteoarthritis

Coding Corner Answer

Staff  |  March 1, 2009

March’s Coding Answer

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingOsteoarthritis

What Subliminal Cues Are Lurking in Your Waiting Room?

Staff  |  March 1, 2009

The current managed care environment and declining reimbursement rates are forcing physicians to see more patients to break even. With a constant stream of new patients and appointments booked back to back, waiting has become an unavoidable patient experience in healthcare. In fact, many patients spend more time in the waiting room than in an exam room with a physician.

Filed under:From the CollegePractice Support Tagged with:PatientsPractice ManagementPractice Updates

Quality Measures and Reporting

Sherine Gabriel, MD  |  March 1, 2009

A call for professional responsibility

Filed under:President's Perspective Tagged with:Centers for Medicare & Medicaid Services (CMS)EHREMRQuality

The Gender Effect

Kurt Ullman  |  March 1, 2009

Are gender-based differences in rheumatic and autoimmune disease clinically relevant or statistical artifact?

Filed under:Conditions Tagged with:AutoimmuneGendergenetics

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2009

Information on safety, labeling changes, and pharmaceutical research

Filed under:Drug Updates Tagged with:ApprovalsPipeline

Help Patients with Scleroderma Manage Musculoskeletal and Functional Limitations

Staff  |  February 1, 2009

On March 10, Janet Poole, PhD, OTR, professor of the occupational therapy graduate program at the University of New Mexico in Albuquerque, will continue the ARHP’s Audioconference/Webcast Series with the management of scleroderma. Dr. Poole received her BS in occupational therapy from Colorado State University, her MA degree in educational psychology from the University of North Carolina, Chapel Hill, and her PhD in motor learning/motor control from the University of Pittsburgh. Dr. Poole’s research interest is in scleroderma and the functional impact of the disease on the tasks of daily living, oral hygiene, parenting, and employment. She has conducted a number of studies examining rehabilitation interventions with people who have scleroderma and, with a colleague, is developing a self-management program for these patients. She has also authored several textbook chapters on rehabilitation for people with scleroderma.

Filed under:From the College Tagged with:Association of Rheumatology Professionals (ARP)ManagementSclerodermaTreatment

  • « Previous Page
  • 1
  • …
  • 226
  • 227
  • 228
  • 229
  • 230
  • …
  • 243
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences